FDA Approves EPA-Only Omega-3 PUFA Capsule for High TG
05:06 EDT 27 Jul 2012 | Medscape
Unlike already-available Lovaza, VASCEPA contains only eicosapentaenoic acid as the active omega-3 ingredient. FDA Approvals
Original Article: FDA Approves EPA-Only Omega-3 PUFA Capsule for High TG
More From BioPortfolio on "FDA Approves EPA-Only Omega-3 PUFA Capsule for High TG"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
